Citation Impact

Citing Papers

Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
2015
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
2019
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Cancer statistics, 2020
2020 Standout
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
2017 Standout
An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis
2020 StandoutNobel
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Phagocytosis checkpoints as new targets for cancer immunotherapy
2019
Macrophages in immunoregulation and therapeutics
2023 Standout
Targeting innate sensing in the tumor microenvironment to improve immunotherapy
2019
Hepatocellular carcinoma
2021 Standout
Immune crosstalk in cancer progression and metastatic spread: a complex conversation
2020
Targeting tumor-associated macrophages to synergize tumor immunotherapy
2021
Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration
2017
The role of the IL-22/IL-22R1 axis in cancer
2014
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
2010 StandoutNobel
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
2018
The role of regulatory T cells in cancer immunology
2015
Biological and pathological activities of interleukin-22
2016
HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway
2016
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer
2022
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Mycobacterium tuberculosis-Induced Polarization of Human Macrophage Orchestrates the Formation and Development of Tuberculous Granulomas In Vitro
2015
Suppression of tumour-specific CD4 + T cells by regulatory T cells is associated with progression of human colorectal cancer
2011
The role of innate immunity in the immunopathology and treatment of HBV infection
2016
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
2019 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Novel patient-derived preclinical models of liver cancer
2020
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Chronic viral hepatitis and its association with liver cancer
2017
Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α through mTOR-dependent pathway
2014
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Role of Human Macrophage Polarization in Inflammation during Infectious Diseases
2018 Standout
Abdominal pain in quadriparesis: myofascial syndrome as unsuspected cause.
1984
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Prevalence of myofascial pain in general internal medicine practice.
1989 Standout
In vivo models of hepatitis B and C virus infection
2016
Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity
2021
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Genetic Dissection of the Host Tropism of Human-Tropic Pathogens
2015

Works of Yan Luan being referenced

CTLA-4 Limits Anti-CD20–Mediated Tumor Regression
2016
Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment
2013
Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis
2019
Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion
2018
Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
2014
Accumulation of Foxp3+ T Regulatory Cells in Draining Lymph Nodes Correlates with Disease Progression and Immune Suppression in Colorectal Cancer Patients
2010
Rankless by CCL
2026